Tag: IMGN

Finance

5 Stocks Under Wall Street’s Radar : Alibaba Group (NYSE:BABA), JD.com, Inc. (NASDAQ:JD), ImmunoGen (NASDAQ:IMGN), Oracle Corporation (NYSE:ORCL), CCA Industries Inc. (NYSEMKT:CAW),

Citi announced that Alibaba Group Holding Ltd (NYSE:BABA) has appointed Citi’s Issuer Services business, acting through Citibank, N.A., as the depositary bank for its American Depositary Receipt (“ADR”) program. Alibaba Group’s ADRs, which began trading on September 19, 2014, represent the largest Depositary Receipt program in initial public offering market history. Alibaba Group Holding Ltd (NYSE:BABA) belongs to Services sector. On last trading day company … Continue reading 5 Stocks Under Wall Street’s Radar : Alibaba Group (NYSE:BABA), JD.com, Inc. (NASDAQ:JD), ImmunoGen (NASDAQ:IMGN), Oracle Corporation (NYSE:ORCL), CCA Industries Inc. (NYSEMKT:CAW),

Kristen Barton
Finance

Hot Alert : ImmunoGen (NASDAQ:IMGN), Walt Disney Company (NYSE:DIS), Shanda Games Limited (NASDAQ:GAME), EQT Midstream Partners, LP (NYSE:EQM), Northeast Bancorp (NASDAQ:NBN)

The National Institute of Health and Care Excellence (NICE) – the drugs advisory body to the National Health Service (NHS) in the UK – has criticized Roche Holding Ltd. (ADR) (RHHBY) over its refusal to cut prices for Kadcyla, which is used to treat severe cases of breast cancer. Kadcyla is approved to treat HER2-positive breast cancer that has spread to other parts of the … Continue reading Hot Alert : ImmunoGen (NASDAQ:IMGN), Walt Disney Company (NYSE:DIS), Shanda Games Limited (NASDAQ:GAME), EQT Midstream Partners, LP (NYSE:EQM), Northeast Bancorp (NASDAQ:NBN)

Jason Knox
Finance

Hot Movers: Novartis AG (NYSE:NVS), IMAX Corporation (NYSE:IMAX), ImmunoGen (NASDAQ:IMGN), bluebird bio (NASDAQ:BLUE), Randgold Resources (NASDAQ:GOLD)

Novartis AG (ADR) (NYSE:NVS) announced today the submission of a Biologic License Application (BLA) to the US Food and Drug Administration (FDA) for marketing approval for the use of Bexsero® (Multicomponent Meningococcal Group B Vaccine [recombinant, adsorbed]) to help protect against invasive meningococcal disease caused by serogroup B (meningitis B) in adolescents and young adults from 10 years through 25 years of age. Novartis AG … Continue reading Hot Movers: Novartis AG (NYSE:NVS), IMAX Corporation (NYSE:IMAX), ImmunoGen (NASDAQ:IMGN), bluebird bio (NASDAQ:BLUE), Randgold Resources (NASDAQ:GOLD)

Jayne Crisman